Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 30.80
-0.20 (-0.65%)
Sep 10, 2025, 12:40 PM CST
Sofiva Genomics Market Cap
Sofiva Genomics has a market cap or net worth of 665.08 million as of September 10, 2025. Its market cap has decreased by -50.58% in one year.
Market Cap
665.08M
Enterprise Value
595.25M
Revenue
406.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.80
Market Cap Chart
Since January 5, 2017, Sofiva Genomics's market cap has decreased from 1.70B to 665.08M, a decrease of -60.85%. That is a compound annual growth rate of -10.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 669.40M | -22.40% |
| Dec 31, 2024 | 862.66M | -1.51% |
| Dec 29, 2023 | 875.86M | 11.72% |
| Dec 30, 2022 | 784.00M | -24.75% |
| Dec 30, 2021 | 1.04B | -4.66% |
| Dec 31, 2020 | 1.09B | -27.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 399.39B |
| PharmaEssentia | 172.96B |
| Bora Pharmaceuticals Co., LTD. | 93.08B |
| Lotus Pharmaceutical | 50.89B |
| Lumosa Therapeutics | 44.14B |
| Oneness Biotech | 37.16B |
| Polaris Group | 29.70B |
| Pell Bio-Med Technology | 28.71B |